Andrew Hore

Andrew Hore is the publisher of AIM Journal, which is an online monthly publication covering the Alternative Investment Market.

Oxford Metrics already on course for full year forecast

AIM movers: Genedrive test approval and ex-dividends

AdEPT Technology agrees bid from better-funded rival

Songtradr snaps up music streaming technology company 7digital

AIM movers: URU Metals discovers higher grade and Sosandar raises cash

AIM movers: Zinc Media momentum and Bens Creek selling

AIM movers: Pressure Technologies contract and IOG admits Southwark well uncommercial

Aquis weekly movers: S-Venture directors share buying

AIM weekly movers: Vast Resources share price trebles

AIM movers: Conroy Gold intersections and Petro Matad slumps on fundraising

AIM movers: Immotion cash return and ex-dividends

Why companies left AIM in December

Additional FDA approval for Polarean Imaging diagnostic product

AIM movers: Pathfinder Minerals option exercised and Orcadian Energy funding

New AIM admission: Celsius Resources Ltd

AIM movers: Vast Resources increases production and Nicola Foulston ousted at RBG Group

Strong fourth quarter for Porvair

AIM movers: Online Blockchain Rocky Horror NFTs and Rosslyn Data ARR improves

Hargreaves Services at a discount

Bestway builds stake in J Sainsbury

Aquis weekly movers: Chris Akers increases Asimilar stake

AIM weekly movers: Inspecs share price recovery

AIM movers: Sovereign Metals drilling release expected and Alpha Growth NAV decline

Inspecs sees improvement and ex-dividends

Profit upgrade for Time Finance

AIM movers: RUA Life Sciences global partnership and Inland Homes sells land

Dekel Agri-Vision buys cashew minority

AIM movers: Norman Broadbent

CyanConnode raising £5m to accelerate expansion

AIM movers: Sosandar third party deal with Sainsbury and Audioboom misses expectations

Xpeng – the Tesla rival whose shares have rallied 315% in two months

23/11/2020

‘End of Austerity’ promise hashed out during PMQs

10/10/2018

Brexit: 5,000 City jobs could leave UK

10/10/2018

Advanced Oncotherapy shares soar after cancer treatment milestone

10/10/2018

Two reasons Travelodge backers can expect sleepless nights

24/07/2020